Miguel A Sanz Selected Research

Acute Promyelocytic Leukemia

1/2021	Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia.
1/2021	Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission.
10/2020	Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia.
5/2020	PLZF-RARα, NPM1-RARα, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.
1/2020	Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study.
1/2020	NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia.
1/2020	Advances in the management of coagulopathy in acute promyelocytic leukemia.
11/2019	Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
1/2019	Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia.
1/2019	Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel A Sanz Research Topics

Disease

50	Acute Promyelocytic Leukemia 01/2021 - 02/2004
36	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 04/2005
22	Leukemia 12/2021 - 09/2003
12	Infections 12/2020 - 07/2002
12	Neoplasms (Cancer) 01/2019 - 07/2002
11	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 06/2003
10	Hemorrhage 01/2020 - 10/2005
8	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020 - 06/2003
8	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2017 - 02/2008
7	Fever (Fevers) 10/2011 - 07/2002
6	Multiple Myeloma 02/2015 - 02/2009
4	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2007
4	Residual Neoplasm 01/2018 - 01/2002
3	Mycoses (Diseases, Fungus) 09/2019 - 08/2006
3	Neutropenia 06/2010 - 07/2002
3	Febrile Neutropenia 04/2009 - 07/2002
2	Virus Diseases (Viral Diseases) 12/2020 - 01/2019
2	Thrombosis (Thrombus) 01/2020 - 01/2007
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 03/2007
2	Sepsis (Septicemia) 04/2015 - 12/2005
2	Drug-Related Side Effects and Adverse Reactions 03/2014 - 10/2013
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2012 - 12/2006
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 03/2012 - 09/2009
2	Thrombotic Thrombocytopenic Purpura 12/2010 - 10/2002
2	Blast Crisis (Blast Phase) 11/2010 - 11/2003
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2010 - 11/2003
2	Chromosome Aberrations (Chromosome Abnormalities) 03/2010 - 11/2003
2	Multiple Sclerosis 11/2009 - 10/2008
2	Tumor Lysis Syndrome 01/2008 - 09/2003
2	Lymphoma (Lymphomas) 08/2006 - 09/2003
1	Stillbirth 04/2020
1	Obesity 03/2020
1	Human Influenza (Influenza) 01/2020

Drug/Important Bio-Agent (IBA)

37	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021 - 02/2004
21	AnthracyclinesIBA 01/2019 - 02/2004
12	Arsenic Trioxide (Trisenox)FDA Link 12/2021 - 09/2005
10	Busulfan (Busulfex)FDA Link 01/2017 - 06/2003
8	Inosine Triphosphate (ITP)IBA 01/2021 - 02/2008
7	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2021 - 02/2008
5	fludarabineIBA 05/2018 - 04/2015
5	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2018 - 04/2008
5	Melphalan (Alkeran)FDA LinkGeneric 04/2015 - 02/2009
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020 - 06/2003
4	romiplostim FDA Link 05/2012 - 02/2008
3	fms-Like Tyrosine Kinase 3IBA 06/2022 - 12/2014
3	Retinoic Acid Receptor alphaIBA 12/2021 - 04/2010
3	midostaurinIBA 01/2021 - 01/2017
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2018 - 05/2008
3	Protein Isoforms (Isoforms)IBA 11/2015 - 10/2011
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2015 - 09/2013
3	HLA Antigens (Human Leukocyte Antigens)IBA 04/2015 - 10/2011
3	Drug CombinationsIBA 08/2014 - 10/2013
3	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2010 - 10/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2009 - 07/2002
3	EnzymesIBA 07/2007 - 12/2006
3	AminoglycosidesIBA 12/2005 - 07/2002
2	Prednisone (Sone)FDA LinkGeneric 12/2020 - 01/2011
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2020 - 09/2013
2	Biological ProductsIBA 10/2020 - 04/2010
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2007
2	AntigensIBA 01/2020 - 01/2006
2	AnticoagulantsIBA 01/2020 - 01/2007
2	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 10/2010
2	plerixafor FDA Link 05/2018 - 01/2018
2	Monoclonal AntibodiesIBA 01/2017 - 11/2004
2	nuclear pore complex protein 98IBA 11/2014 - 01/2011
2	Fluconazole (Zonal)FDA LinkGeneric 04/2012 - 09/2007
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2011 - 03/2007
2	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 04/2009 - 05/2005
2	GlycopeptidesIBA 04/2009 - 12/2005
2	CreatinineIBA 04/2008 - 08/2006
2	Allopurinol (Remid)FDA LinkGeneric 01/2008 - 09/2003
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 07/2007 - 03/2007
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 07/2007 - 03/2007
2	Cytochrome P-450 CYP3AIBA 07/2007 - 03/2007
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 05/2005 - 07/2002
2	beta-LactamsIBA 05/2005 - 07/2002
2	Amikacin (A.M.K)FDA LinkGeneric 05/2005 - 07/2002
1	Tyrosine Kinase InhibitorsIBA 06/2022
1	Azacitidine (5 Azacytidine)FDA Link 05/2022
1	Decitabine FDA Link 05/2022
1	BI 6727IBA 08/2021
1	Phosphotransferases (Kinase)IBA 08/2021
1	Sirolimus (Rapamycin)FDA Link 11/2020
1	LipidsIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Hemostatics (Antihemorrhagics)IBA 01/2020

Therapy/Procedure

33	Therapeutics 12/2021 - 07/2002
32	Drug Therapy (Chemotherapy) 08/2021 - 01/2002
22	Transplantation 12/2020 - 01/2004
12	Stem Cell Transplantation 01/2020 - 08/2006
6	Hematopoietic Stem Cell Transplantation 01/2021 - 06/2003
3	Aftercare (After-Treatment) 01/2020 - 09/2008
2	Salvage Therapy 11/2019 - 02/2009
2	Cell Transplantation 11/2017 - 03/2016
2	Remission Induction 04/2010 - 04/2008
1	Haploidentical Transplantation 11/2020
1	Induced Abortion (Induced Abortions) 04/2020
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2020